Literature DB >> 11113047

Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?

M H Rubenstein1, L C Harrell, B V Sheynberg, H Schunkert, H Bazari, I F Palacios.   

Abstract

BACKGROUND: Patients with end-stage renal disease undergoing conventional balloon angioplasty have reduced procedural success and increased complication rates. This study was designed to determine the immediate and long-term outcomes of patients with varying degrees of renal failure undergoing percutaneous coronary intervention in the current device era. METHODS AND
RESULTS: We compared the immediate and long-term outcomes of 362 renal failure patients (creatinine >1.5 mg/dL) with those of 2972 patients with normal renal function who underwent percutaneous coronary intervention between 1994 and 1997. Patients with renal failure were older and had more associated comorbidities. They had reduced procedural success (89.5% versus 92.9%, P:=0.007) and greater in-hospital combined major event (death, Q-wave myocardial infarction, emergent CABG; 10.8% versus 1.8%; P:<0.0001) rates. Renal failure was an independent predictor of major adverse cardiac events (MACEs) (OR, 3.41; 95% CI, 1.84 to 6.22; P:<0.00001). Logistic regression analysis identified shock, peripheral vascular disease, balloon angioplasty strategy, and unstable angina as independent predictors of in-hospital MACEs in the renal group. Compared with 362 age- and sex-matched patients selected from the control group, patients with renal failure had a lower survival rate (27.7% versus 6.1%, P:<0.0001) and a greater MACE rate (51% versus 33%, P:<0.001) at long-term follow-up. Cox regression analysis identified age and PTCA strategy as independent predictors of long-term MACEs in the renal group. Finally, within the renal failure population, the dialysis and nondialysis patients experienced remarkably similar immediate and long-term outcomes.
CONCLUSIONS: Although patients with renal failure can be treated with a high procedural success rate in the new device era, they have an increased rate of major events both in hospital and at long-term follow-up. Nevertheless, utilization of stenting and debulking techniques improves immediate and long-term outcomes.

Entities:  

Mesh:

Year:  2000        PMID: 11113047     DOI: 10.1161/01.cir.102.24.2966

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

Review 1.  Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.

Authors:  Ayman A El-Menyar; Jassim Al Suwaidi; David R Holmes
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

2.  Deterioration of renal function at stent implantation can predict long-term outcome after stent thrombosis.

Authors:  Vojko Kanic; Meta Penko; Franjo Husam Naji; Robert Ekart; Zlatka Kanic; Dejan Dinevski; Radovan Hojs
Journal:  Wien Klin Wochenschr       Date:  2015-09-16       Impact factor: 1.704

Review 3.  Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients.

Authors:  Lisa M Miller; Manish M Sood; Amy R Sood; Martina Reslerova; Paul Komenda; Claudio Rigatto; Joe Bueti
Journal:  Int Urol Nephrol       Date:  2010-10-20       Impact factor: 2.370

4.  The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction.

Authors:  Hans-Peter Hobbach; C Michael Gibson; Robert P Giugliano; Julia Hundertmark; Christel Schaeffer; Wassillij Tscherleniak; Peter Schuster
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

5.  Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease.

Authors:  Gjin Ndrepepa; Franz-Josef Neumann; Salvatore Cassese; Massimiliano Fusaro; Ilka Ott; Stefanie Schulz; Petra Hoppmann; Gert Richardt; Karl-Ludwig Laugwitz; Heribert Schunkert; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2013-10-04       Impact factor: 5.460

6.  Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early and predominantly with percutaneous coronary intervention.

Authors:  C Mueller; F-J Neumann; A P Perruchoud; H J Buettner
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

7.  Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.

Authors:  Sripal Bangalore; Yu Guo; Zaza Samadashvili; Saul Blecker; Jinfeng Xu; Edward L Hannan
Journal:  J Am Coll Cardiol       Date:  2015-09-15       Impact factor: 24.094

8.  [Kidney insufficiency and cardiovascular disease].

Authors:  B Weidtmann; H Schunkert
Journal:  Internist (Berl)       Date:  2007-08       Impact factor: 0.743

9.  Age and diabetes mellitus associated with worse outcomes after percutaneous coronary intervention in a multi-ethnic Asian dialysis patient population.

Authors:  Jiang Ming Fam; Chun Yuan Khoo; Yee How Lau; Weng Kit Lye; Xinzhe James Cai; Lina Hui Lin Choong; John Carson Allen; Khung Keong Yeo
Journal:  Singapore Med J       Date:  2020-03-17       Impact factor: 1.858

10.  Coronary Stents in Patients with ST-Elevation Myocardial Infarction and Chronic Kidney Disease Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Khurshid Ahmed; Myung Ho Jeong; Rabin Chakraborty; Sumera Ahmed; Young Joon Hong; Doo Sun Sim; Keun Ho Park; Ju Han Kim; Youngkeun Ahn; Jung Chaee Kang; Myeong Chan Cho; Chong Jin Kim; Young Jo Kim
Journal:  Korean Circ J       Date:  2012-12-31       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.